5 Best Medical Stocks Under $10

In this piece, we will take a look at the five best medical stocks under $10. If you want to take a deeper look at the different segment of the medical industry and more stocks, head on over to 11 Best Medical  Stocks Under $10.

5. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

Number of Hedge Fund Investors In Q1 2023: 32

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is a biotechnology company based in Durham, North Carolina. The firm is one of the older companies on our list, set up in 1986. It develops medicines for a variety of diseases and ailments such as the Zika virus, Yellow Fever, and the Ebola virus.

After digging through 943 hedge funds for their first quarter of 2023 investments, Insider Monkey discovered that 32 had bought a stake in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX). Julian Baker and Felix Baker’s Baker Bros. Advisors is the firm’s largest hedge fund investor in our database since it owns 12.7 million shares that are worth $106 million.

4. Bausch Health Companies Inc. (NYSE:BHC)

Number of Hedge Fund Investors In Q1 2023: 32

Bausch Health Companies Inc. (NYSE:BHC) is a Canadian firm operating out of Laval, Canada. It is a diversified medicine manufacturer, making products for several different diseases of the eyes, nerves, skin, and digestive system. Bausch Health Companies Inc. (NYSE:BHC) also makes medical devices and the firm was founded in 2013.

Insider Monkey’s March quarter of 2023 survey covering 943 hedge funds revealed that 32 had bought and owned the medical company’s shares. Bausch Health Companies Inc. (NYSE:BHC)’s biggest shareholder is Carl Icahn’s Icahn Capital LP with a $281 million stake.

3. CymaBay Therapeutics, Inc. (NASDAQ:CBAY)

Number of Hedge Fund Investors In Q1 2023: 35

CymaBay Therapeutics, Inc. (NASDAQ:CBAY) is a California based biotechnology company. It is developing treatments for liver disease and complications resulting from diabetes. The company also has partnerships with other companies to develop drugs and share research.

35 of the 943 hedge funds part of Insider Monkey’s Q1 2023 database had invested in CymaBay Therapeutics, Inc. (NASDAQ:CBAY). Kurt Von Emster’s VenBio Select Advisor is its largest hedge fund investor with an $89 million stake.

2. Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Number of Hedge Fund Investors In Q1 2023: 35

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the largest and oldest companies on our list. It was set up in 1901 and is based in Tel Aviv, Israel. It is a diversified medicine and drug manufacturing firm, providing treatment for ailments such as migraine and sclerosis.

As of March 2023, 35 of the 943 hedge funds profiled by Insider Monkey bought the firm’s shares. Teva Pharmaceutical Industries Limited (NYSE:TEVA)’s largest hedge fund shareholder is Ken Griffin’s Citadel Investment Group with an $84 million investment.

1. Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)

Number of Hedge Fund Investors In Q1 2023: 40

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is a unique medical firm in the sense that it seeks to leverage a cancer patient’s immune system to stimulate it and fight the deadly disease. It develops treatments for melanoma, lung cancer, and cervical cancer.

Insider Monkey dug through 943 hedge funds for their first quarter of 2023 shareholdings and discovered that 40 had invested in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA). Joseph Edelman’s Perceptive Advisors is the medical company’s largest shareholder since it owns $93 million worth of shares.

Disclosure: None. You can also take a look at 15 Most Profitable Drugs In The World and 20 Most Used Prescription Drugs In The US.

Follow Insider Monkey on Twitter